C4 Therapeutics, Inc. · NASDAQ:CCCC

Anderson Kenneth Carl received 4,259 C4 Therapeutics, Inc. shares as an award (Form 4)

Traded Apr 1, 2026 · Filed Apr 3, 2026

On Apr 1, 2026, Anderson Kenneth Carl (Director) received 4,259 C4 Therapeutics, Inc. shares as an award at US$2.70 for US$11,499, leaving 68,230 shares. Filed Apr 3, 2026 (Form 4).

Awarded
4,259 shares
Price
US$2.70
Value
US$11,499
Holding after
68,230 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 1, 2026Common StockAward4,259US$2.7068,230Direct

Source

View original at SEC

Related